Telehealth in Lewy Body Dementia
NCT05014971
Summary
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Eligibility
Participant with Lewy Body Dementia (LBD) Inclusion Criteria: * LBD diagnosis by a dementia or movement disorders specialist * Clinician-determined mild-moderate dementia severity * Internet access with a Zoom-compatible device * Caregiver who resides in the patient's home and is willing to participate * Fluency in English
Conditions4
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05014971